None listed
Conditions
Interventions
Drug : All subjects are randomly divided into three groups, and an fascial iliac compartment block is performed once under ultrasound guidance.
Group ER is administered 40cc of 0.2% ropivacaine (40mg/
Sponsors
Jeonbuk National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? Patients receiving THA under general anesthesia for regular surgery ? A person who voluntarily decided to participate and gave written consent after hearing an explanation of the characteristics of this clinical trial and clinical trial drugs ? Male and female patients between the ages of 19 and 90 ? Patients with American Society of Anesthesiologist Physical Status I – III
Exclusion criteria
Exclusion criteria: ? Patients who are expected to have difficulties in cooperating (intellectually disabled patients or delirium, moderate to severe dementia or severe psychiatric disorders) ? Alcohol or psychoactive drug dependence ? Contraindications to injection (coagulopathy, allergy) ? Patients with abnormal blood clotting levels (prothrombin time, abnormal platelet count, etc.) ? American Society of Anesthesiology Patient Body Grade 4 or higher ? Patients who want spinal anesthesia ? Pregnant or lactating women ? Simultaneous implementation of both sides ? Second surgery performed within 1 week in case of staging op. ? Revision arthroplasty (revision op.) ? Cases in which hemoglobin reduction is expected to overlap due to fractures or surgery in other parts ? Cases in which prosthetic replacement is performed several times with an operation time of more than 2 hours ? Patients who do not want their own pain control system
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| estimated blood loss, EBL | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemodynamic variability;pain after surgery | — |
Countries
Korea, Republic of
Contacts
Public ContactSeon Woo Yoo
Jeonbuk National University Hospital
Outcome results
None listed